The US Opioid Epidemic: Where Do We Go from Here?: A Health Policy and Bioethics Consortium
Description
The US has struggled with an epidemic of prescription opioid overuse and abuse, which has contributed to an uptick in illegal drug use and affected communities across the country. Numerous states and organizations have tried different approaches to address the epidemic, including limitations on prescriptions and improving access to treatment modalities. Five years into the crisis, can we begin to understand the advantages and disadvantages of different approaches to addressing the opioid epidemic? Which policies have been most effective?
This event was free and open to the public.
Panelists
-
Jessie M. Gaeta, MD, Chief Medical Officer, Boston Health Care for the Homeless
-
Andrew Kolodny, MD, Co-Director, Opioid Policy Research Center, Heller School for Social Policy and Management, Brandeis University
The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations.
They are organized by the Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.
Video
VIDEO: Watch the full event via the Center for Bioethics at Harvard Medical School!
Tags
addiction bioethics health law policy health policy and bioethics consortia pharmaceuticals public health regulation